Skip to content

Descemet Membrane Endothelial Keratoplasty (DMEK)

Prospective Clinical Study on Descemet Membrane Endothelial Keratoplasty (DMEK)

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT00521898
Acronym
DMEK
Enrollment
1000
Registered
2007-08-28
Start date
2005-02-28
Completion date
2020-02-29
Last updated
2023-01-12

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Corneal Dystrophies, Hereditary

Keywords

Corneal transplantation, Descemet membrane

Brief summary

To evaluate isolated Descemet membrane transplantation as a refinement of previous advanced techniques for corneal transplantation, like Descemet Stripping Endothelial Keratoplasty (DSEK)

Detailed description

See above.

Interventions

Sponsors

Amnitrans Eyebank Rotterdam
CollaboratorOTHER
Netherlands Institute for Innovative Ocular Surgery
Lead SponsorOTHER

Study design

Allocation
NA
Intervention model
SINGLE_GROUP
Primary purpose
TREATMENT
Masking
NONE

Eligibility

Sex/Gender
ALL
Age
21 Years to No maximum
Healthy volunteers
No

Inclusion criteria

* Corneal endothelial disorders

Exclusion criteria

* N/A

Design outcomes

Primary

MeasureTime frame
Best spectacle corrected visual acuity2005-2015

Secondary

MeasureTime frame
Corneal endothelial cell density2005-2015

Countries

Netherlands

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Apr 3, 2026